3SBio, Inc. (NASDAQ:SSRX) will release the third quarter earnings for 2009 on Thursday, November 12 after the US market closes. The company will hold a conference call at 8:00 am ET the following morning, Friday, November 13 to review the financial results. Interested parties may participate in the call by dialing one of the following numbers:
China, landline: 800.819.0121
China, mobile: 400.620.8038
International toll free
Honk Kong: 800930346
United Kingdom: 808.8234.6646
United States: 1.866.519.4004
International toll: 65.6735.7955
The conference ID number is 38479039.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter.
Those who are unable to participate may hear a replay of the call. The replay will be available from two hours after the call to November 20, 2009. The number for the replay is 61.2.8235.5000 for international listeners or 1.866.214.5335 for US listeners. The replay conference ID will be 38479039. A webcast of the presentation will also be available one hour after the event at http://bbs.3sbio.com/en/News/xinvestors.aspx.
3SBio Inc. is an integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. The Company’s recombinant, or genetically engineered, protein-based products and product candidates are designed to address markets with unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. Its principal products are EPIAO and TPIAO, and its legacy products are Intefen and Inleusin. EPIAO is an injectable recombinant human erythropoietin (EPO) that is used to stimulate the production of red blood cells in patients with anemia and to reduce the need for blood transfusions. 3SBio Inc. had launched TPIAO, its internally developed protein-based therapeutic product. In addition to EPIAO and TPIAO, the Company markets two other protein-based therapeutics.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
About Best Damn Penny Stocks
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
